The Subcutaneous Administration of Beta-Lactams: A Case Report and Literary Review—To Do Small Things in a Great Way

Author:

Leanza Gabriele Maria1ORCID,Liguoro Beatrice1,Giuliano Simone2ORCID,Moreal Chiara3ORCID,Montanari Luca3,Angelini Jacopo4,Cai Tommaso56ORCID,Murri Rita17ORCID,Tascini Carlo23ORCID

Affiliation:

1. Dipartimento di Sicurezza e Bioetica, Università Cattolica del S. Cuore, 00168 Rome, Italy

2. Infectious Diseases Clinic, Azienda Sanitaria Universitaria del Friuli Centrale (ASUFC), 33100 Udine, Italy

3. Infectious Diseases Clinic, Department of Medicine (DAME), University of Udine, 33100 Udine, Italy

4. Pharmacology Institute, Azienda Sanitaria Universitaria del Friuli Centrale (ASUFC), 33100 Udine, Italy

5. Department of Urology, Santa Chiara Regional Hospital, 38123 Trento, Italy

6. Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway

7. Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy

Abstract

The subcutaneous (s.c.) route is a commonly used method for delivering various drugs, although its application in the administration of antibiotics is relatively uncommon. In this case, we report a successful treatment of nosocomial pneumonia using piperacillin/tazobactam via continuous subcutaneous administration. Furthermore, this article provides an overview of the current literature regarding the s.c. administration of beta-lactam antibiotics. Based on our analysis, we identified only 15 studies that described the s.c. use of beta-lactam antibiotics in human subjects. Among these studies, cephalosporins were the most extensively investigated antibiotic class, with 10 available studies. According to the study findings, all three antibiotic classes (cephalosporins, penicillins, and carbapenems) demonstrated a similar pharmacokinetic profile when administered via the subcutaneous route. The subcutaneous route appears to be associated with a lower peak serum concentration (Cmax) but a comparable minimum blood concentration (Cmin) and an extended half-life (t1/2) when compared to conventional routes of antibiotic administration. Further research is necessary to determine whether subcutaneously administered beta-lactam antibiotics in human subjects achieve pharmacodynamic targets and demonstrate clinical efficacy.

Publisher

MDPI AG

Subject

Infectious Diseases

Reference30 articles.

1. Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis;Tacconelli;Lancet Infect. Dis.,2018

2. Erratic absorption of intramuscular antimicrobial delivery in infants and children;Expert. Opin. Drug Metab. Toxicol.,2007

3. Rowland, M., and Tozer, T.Z. (1995). Clinical Pharmacokinetics: Concepts and Applications, Lippincott Williams & Wilkins. [3rd ed.]. Chapter 9.

4. Ritschel, W.A., and Kearns, G.L. (2004). Handbook of Basic Pharmacokinetics. Including Clinical Applications, American Pharmacists Association. [6th ed.].

5. Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administration;Borner;Chemotherapy,1985

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3